Physician profile
William E Garvis
NPI 1780686584
$326.79
in general payments reported to CMS, 2019-2025
8 companies · $52.05 in 2025
The $52.05 reported for 2025 was less than what a typical Otology & Neurotology provider received nationally (typical 2025 total: $411).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $48.26 · 2020: $102 · 2022: $37.30 · 2023: $68.16 · 2024: $18.85 · 2025: $52.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $139.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $139.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intersect Ent, INC. | $116.56 | 2019-2020 | |
| Hologic Sales and Service, LLC | $46.93 | 2023-2025 | Coolseal Generator |
| Optinose US, INC. | $46.82 | 2020-2024 | |
| Cochlear Americas | $33.79 | 2023 | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha, Osia Osi300 Implant |
| Novartis Pharmaceuticals Corporation | $22.81 | 2019 | |
| Merck Sharp & Dohme LLC | $22.58 | 2025 | Keytruda |
| Aerin Medical INC. | $20.33 | 2022 | |
| Glaxosmithkline, LLC. | $16.97 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Garvis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.